In the News & Press Releases

Press Release Archives:

2011 | 2010 | 2009

January 22, 2013 - Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office PDF

January 7, 2013
Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference PDF

November 12, 2012
Cato BioVentures will Attend the 18th Annual BIO-Europe 2012 Conference and Host a Wine Tasting at One of their Offices in Germany PDF

November 8, 2012
Cato Research expert William Lee, Ph.D., R.A.C., Vice President of Regulatory Affairs at Cato Research will present at BIT's 10th Anniversary of International Drug Discovery Science and Technology at the Nanjing International Expo Center Jinling Convention Center (JLCC) in China. PDF

October 4, 2012
Cato Research and GlobalSubmit Cohost Free Educational Webinar on FDA Regulatory Electronic Submissions for the Life Science Industry 

August 13, 2012
Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Collaboration with Cato Research - Pluristem Therapeutics Inc announced that it has signed a new collaboration agreement with Cato Research as its contract research organization (CRO) for the German portion of the Company’s Phase II trial in Intermittent Claudication (IC) under the auspices of the Paul-Ehrlich Institute (PEI).

July 31, 2012
Cancer Advances, Inc. (Cancer Advances), a wholly owned, biotechnology portfolio company of Cato BioVentures, announces the issuance of a new patent for a companion diagnostic 

May 3, 2012
Cato Research Canada Celebrates 20 Years of Successful Drug Development And Welcomes Many More Decades to Come 

March 2012
Cato Research participates in Business North Carolina's Biotechnology Round Table

February 8, 2012
VistaGen Therapeutics Increases Its Drug Rescue Opportunities with Right-of-First-Offer Agreement with Cato BioVentures and Cato Research

December 2, 2011
Cato Research presents on FDA regulation of mHealth devices at KOTRA M2M Tech Partnership

November 2011
Cato Research was named the #2 Healthiest Employer by the Triangle Business Journal.

May 16, 2011NeuroHealing Announces Strategic Master Services and Investment Agreement with Cato BioVentures

February 10, 2011Cato Research Expands Relationship with Merge Healthcare to include myEDC™ for Early Phase Trials

January 10, 2011
Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAP